Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Donovan Joanne M. sold 9,441 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Aug 12 to Aug 13, 2026 · Filed Aug 14, 2026
From Aug 12 to Aug 13, 2026, Donovan Joanne M. (CMO) sold 9,441 Edgewise Therapeutics, Inc. shares at an average US$43.71 for US$413K, leaving 8,625 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 9,441 shares
- Price
- US$43.71 average (US$43.41 to US$44.52)
- Value
- US$413K
- Holding after
- 8,625 shares
- Trading plan
- No
- Role
- CMO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 5,781 | 11,035 | Direct | |
| Aug 12, 2026 | Common Stock | Option exercise | 7,031 | 18,066 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 2,839 | US$43.78 | 15,227 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 2,779 | US$43.71 | 12,448 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 104 | US$44.43 | 12,344 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 800 | US$44.52 | 11,544 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,919 | US$43.41 | 8,625 | Direct |
Source
Related
- Edgewise Therapeutics, Inc.
- Donovan Joanne M.
- Edgewise Therapeutics, Inc. shareholders
- Form 4 · Donovan Joanne M. · May 5, 2026
- Form 4 · Donovan Joanne M. · Apr 2, 2026
- Form 4 · Fox Jonathan C · Oct 2, 2026
- Form 4 · Russell Alan J · Aug 14, 2026
- Form 4 · Moore John R · Aug 14, 2026
- Form 4 · Derakhshan Behrad · Aug 14, 2026
- Form 4 · Koch Kevin · Aug 14, 2026